関連する実験動画

Updated: Jul 15, 2025

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Published on: April 28, 2022

アミロイドの冷凍-EMによる神経変性疾患の分子病理学

Sjors H W Scheres¹, Benjamin Ryskeldi-Falcon², Michel Goedert³

¹Medical Research Council Laboratory of Molecular Biology, Cambridge, UK. scheres@mrc-lmb.cam.ac.uk.

|September 27, 2023

まとめ

特定のアミロイド構造であるタウとアミロイドβは神経変性疾患を定義します Cryo-EMは原子構造を明らかにしアルツハイマー病やパーキンソン病などの病気を理解し治療法を開発するのに役立ちます

科学分野:

神経科学
生物化学
構造生物学

背景:

ほとんどのヒトの神経変性疾患は,タウ,α-シヌクレイン,TDP-43,およびアミロイド-βなどのタンパク質がアミロイドフィラメントに異常な集積によって特徴付けられます.
遺伝的要因は,タンパク質のフィラメント形成と病因を直接関連付けています.
クリオ電子顕微鏡 (cryo-EM) の進歩により,ヒトの脳組織からアミロイドの原子レベルの構造的決定が可能になりました.

研究の目的:

これまでの脳由来アミロイドフィラメントの原子構造を調べる
これらの構造が神経変性研究に与える影響について議論する.
特定のアミロイドの折りたたみが特定の病気を定義する役割を強調する.

主な方法:

低温電子顕微鏡 (cryo-EM) 研究のレビュー
死後の人間の脳のアミロイドフィラメントの原子構造の分析
特定のタンパク質構造と神経病理学的相関.

主要な成果:

単一のタンパク質は様々なアミロイドフィラメント構造を形成する.
明確なアミロイドの折り合いは特定の神経変性疾患の特徴です.
アミロイド構造は神経病理学の原子レベルの説明を提供します.

結論:

アミロイド構造は神経変性疾患の理解と研究に根本的な基盤を提供する.
将来の研究は,病気に関連したアミロイド構造を模倣するモデルシステムを活用すべきである.
これらの構造を理解することは神経変性疾患の診断と治療の改善に不可欠です

さらに関連する動画

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

Use of Two Dimensional Semi-denaturing Detergent Agarose Gel Electrophoresis to Confirm Size Heterogeneity of Amyloid or Amyloid-like Fibers

Use of Two Dimensional Semi-denaturing Detergent Agarose Gel Electrophoresis to Confirm Size Heterogeneity of Amyloid or Amyloid-like Fibers

Published on: April 26, 2018

関連する概念動画

Cryo-electron Microscopy

Cryo-electron Microscopy

Conventional electron microscopy (EM) involves dehydration, fixation, and staining of biological samples, which distorts the native state of biological molecules and results in several artifacts. Also, the high-energy electron beam damages the sample and makes it difficult to obtain high-resolution images. These issues can be addressed using cryo-EM, which uses frozen samples and gentler electron beams. The technique was developed by Jacques Dubochet, Joachim Frank, and Richard Henderson, for...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...